Isivivinyo se-ELARA, i-follicular lymphoma, UKymriah, I-NCT03568461, I-Novartis, Ukulinganisa kwenkampani Novartis Pharmaceuticals Corporation, Unyusibhabha
I-Tisagenlecleucel igunyazwe yi-FDA nge-lymphoma ebuyele emuva noma e-refractory follicular
Juni 2022: Ngemva kwemigqa emibili noma ngaphezulu yokwelashwa kwe-systemic, i-FDA yaklomelisa i-tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) yagunyaza ngokushesha iziguli ezikhulile ezine-lymphoma ebuyelelwe emuva noma e-refractory follicular (FL).T..
I-Acalabrutunib, I-Avelumab, Ukwelashwa kwenqola, Dabrafanib, UKymriah, Izidakamizwa zakamuva, I-Midostaurin, I-Niraparib, I-Pembrolizumab, UTecartus, Unyusibhabha, I-Trametinib, USFDA
Izidakamizwa zakamuva ekwelapheni umdlavuza
Julayi 2021: Hlola izidakamizwa zakamuva ekwelapheni umdlavuza. Minyaka yonke, ngemva kokuhlola izivivinyo nezinye izici ezibalulekile, i-USFDA ivuma izidakamizwa, futhi ngaleyo ndlela iziguli ezinomdlavuza manje zingakholwa ukuthi ikhambi seliseduze kakhulu. ..